BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30673774)

  • 1. Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus.
    Broussou DC; Toutain PL; Woehrlé F; El Garch F; Bousquet-Melou A; Ferran AA
    PLoS One; 2019; 14(1):e0211214. PubMed ID: 30673774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
    Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
    Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing
    Broussou DC; Lacroix MZ; Toutain PL; Woehrlé F; El Garch F; Bousquet-Melou A; Ferran AA
    Front Microbiol; 2018; 9():572. PubMed ID: 29636741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro elution of amikacin and vancomycin from impregnated plaster of Paris beads.
    Atilla A; Boothe HW; Tollett M; Duran S; Diaz DC; Sofge J; Boothe DM
    Vet Surg; 2010 Aug; 39(6):715-21. PubMed ID: 20704692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of tigecycline (GAR-936) against Enterococcus faecium and Staphylococcus aureus used alone and in combination.
    Mercier RC; Kennedy C; Meadows C
    Pharmacotherapy; 2002 Dec; 22(12):1517-23. PubMed ID: 12495161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis.
    Rådberg G; Nilsson LE; Kihlström E; Maller R; Sörén L
    J Antimicrob Chemother; 1992 Oct; 30(4):489-96. PubMed ID: 1490921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus.
    Arhin FF; Sarmiento I; Parr TR; Moeck G
    Int J Antimicrob Agents; 2012 Feb; 39(2):159-62. PubMed ID: 22070858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms.
    Giovagnoli S; Pietrella D; Barberini L; Santi C; Carotti A; di Michele A; Ricci M
    Int J Pharm; 2017 Aug; 528(1-2):144-162. PubMed ID: 28596137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.